Pharma Mar | PHM - Debt


Pharma Mar reported EUR45.84M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Almirall EUR 356.11M 13.25M Jun/2026
Avita Medical AUD 48.48M 2.43M Jun/2026
Dianthus Therapeutics USD 1.29M 77K Jun/2026
Ionis Pharmaceuticals USD 1.77B 141M Sep/2026
IQVIA Holdings USD 16.07B 174M Sep/2026
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Moderna USD 1.29B 11M Jun/2026
Organon & Co USD 8.55B 1000K Sep/2026
Pharma Mar EUR 45.84M 1.7M Jun/2026
Revvity USD 2.63B 707.45M Sep/2026
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 13.32B 36.3M Sep/2026
Xeris Pharmaceuticals USD 289.44M 30.89M Jun/2026